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Health surveillance is an essential tool for the achievement of these core public health functions, particularly at a time of rapid change driven by fiscal restraint. Health surveillance helps those responsible for public health change management to know where they are, to assess needs and priorities and to monitor progress toward public health goals.
About 50 years ago, Dr. Alexander Langmuir joined the then recently formed US Communicable Disease Center (CDC). He launched the first-ever disease surveillance program and confirmed his suspicion that malaria, on which CDC spent the largest portion of its budget at that time, had long since disappeared from the United States. Since that time, disease surveillance has grown to be CDC's core function in support of public health practice.
In its recent report "An Integrated National Health Surveillance Network for Canada," 2 the Federal-ProvincialTerritorial (FPT) Surveillance Integration Design Team defined health surveillance as follows:
"The tracking and forecasting of any health event or health determinant through the ongoing collection of data, the integration, analysis and interpretation of those data into surveillance products and the dissemination of such products to those who need to know. Surveillance products are produced for a predetermined public health purpose or policy objective. In order to be considered health surveillance, all of the above activities must be carried out." The single characteristic that makes health surveillance distinct from other health information activities is the requirement for a direct link to a public health purpose or policy objective. In general, it entails organized, population-based data collection on a frequent or continuous basis. Timeliness of surveillance products is usually a requirement. However, health surveillance is a component of the broader field of health information and is highly dependent on health information standards, practices and technologies as well as the legal and ethical constraints of using information about individuals.
If we accept that health surveillance is a measurement tool that serves public health objectives, then it follows that the scope of health surveillance and the methods used must change to meet changing needs. In fact, this has occurred to a considerable degree. Whereas health surveillance was once limited to monitoring the occurrence of infectious diseases, the scope has expanded to include non-infectious diseases, injuries, early detection of emerging and re-emerging diseases and risk behaviours. Data collection methodologies have evolved from paper-based reports to electronically linked administrative health record systems, population surveys and internet-based technologies. Analytic methods have progressed from simple counts and rates to modelling and forecasting.
The Krever Commission Report 3 was the final report of the Commission of Inquiry on the Blood System in Canada. Justice Krever made several recommendations with implications for health surveillance in Canada including: 1) In matters of public health and safety, there is often a need to act in the absence of complete information; the more severe the potential effect, the lower the threshold should be for taking action. By providing information on persons with adverse health outcomes (numbers affected, severity of health effects), health surveillance provides a basis for taking action on factors associated with current health outcomes. 2) Post-marketing surveillance is needed to evaluate the appropriate use of and access to essential products and for early detection of adverse health effects. 3) Surveillance information is needed to inform the public about the performance of the health system so they can provide informed contributions to decision making. 4) Surveillance of the public health system per se is needed to evaluate the adequacy of resources available to implement essential public health policies and programs. Although the scope of the Krever Inquiry was limited to infectious diseases transmissible through blood and blood products, the principles apply equally to the full span of public health services including: 1) Public health policy and risk management: Surveillance identifies health needs and progress in health protection and health promotion. 2) The immediate control of disease:
Timeliness is vitally important in the management of infectious diseases which have the potential to rapidly place many Canadians at risk of serious illness or death. Early detection of infectious disease outbreaks is needed to trigger rapid implementation of control measures and may serve specific legislated mandates (e.g., food safety). There are important secondary uses of surveillance information such as hypothesis generation, population research (e.g., on health services, program evaluation) and the provision of basic information on health status indicators for the public.
There are major gaps in Canada's health surveillance systems. Although we have quite good information on mortality from many diseases and injuries, we only have national population-based incidence data for cancer and HIV/AIDS. It is hard to believe but we have little or no incidence data for most diseases including coronary heart disease, stroke, cirrhosis, diabetes, injuries and other preventable health conditions. Even for cancer, we lack information on extent of disease at diagnosis which is needed to evaluate the impact of cancer screening and treatment programs.
In the area of risk factors and health determinants, we have inadequate or no surveillance systems for drinking water quality, air quality, risk behaviours (although there are developments in this field), nutritional status, physical fitness and access to preventive health services. The absence of basic population-based incidence and exposure information means that we seldom have information on the disease burden attributable to a given risk factor, a very important indicator needed to assess public health priorities. We do not yet have readily accessible risk factor and disease incidence, prevalence and mortality data stratified by income, education and other broad health determinants. Surveillance requires a commitment to collect standardized, comparable measures over time -even this basic requirement is rarely met in practice.
As Canada enters the new millennium, there are other unmet surveillance needs including comprehensive surveillance information on target populations (e.g., low-income groups, children, women, Aboriginals, refugees/migrants and seniors), health consequences of natural disasters, climate extremes and other potential effects of global climate change, hazards related to consumer and commercial products (post-marketing surveillance) and occupational safety and health.
The FPT Surveillance Integration Design Team noted a number of gaps related to specific diseases, but concluded that a more pressing need was to address those needs that many surveillance systems had in common. These include: 1) Common protocols and standards for access to, interpretation and release of data, and for the protection of privacy. 2) Improving access to existing information -inventories of existing databases, metadata and expertise, together with a portal or "single window" means of access, using new technology, particularly to facilitate timely access to data. 3) Developing and adopting standardsfor the classification of diseases, exposures and other health events, data base elements, and for informatics. 4) Developing and sharing innovative electronic means of accessing, integrating, analyzing, presenting and disseminating information. 5) Strengthening the human resources and skills available to perform surveillance across Canada. It is proposed that federal, provincial, local/regional, NGO and academic partners can improve the capacity to undertake surveillance through participation in the proposed network for health surveillance in Canada.
It has been said that, "What gets measured gets done." If one accepts this, then the surveillance gaps and deficiencies alluded to above imply that Canadians are likely not receiving optimal interventions to reduce their risk of preventable illness and premature death. There are, however, signs of progress. The Canadian Coalition on Cancer Surveillance arose from a National Cancer Institute of Canada workshop held at Kananaskis in November 1996. Cooperation between voluntary, professional, provincial and federal agencies led to agreement on needs and priorities for cancer surveillance in Canada and followup activities should achieve improved information such as basic staging data for newly diagnosed cancer patients. Similar activities are underway for cardiovascular disease and diabetes.
Health Canada has undertaken several novel proof-of-concept surveillance projects to test the feasibility of real-time surveillance systems and the strengthening of local/regional/national/global surveillance systems. The Roadmap project under development by Health Canada, Statistics Canada and the Canadian Institute for Health Information is designed to provide improved information on the performance of the health care system and the health status of Canadians. The main thrusts of Roadmap are to create person-oriented health care records, to expand the National Population Health Survey to subprovincial health regions, to improve or create various measures of health care utilization (including use of pharmaceuticals, home care, mental health, addictions, rehabilitation and primary care), to improve data standards and data sharing, strengthen disease registries, and to facilitate costing of health services by developing costing methodologies and mechanisms.
The discussion above has focussed on the need for surveillance to meet one of the core functions of public health, i.e., assessment. Surveillance is also important to achieve the other core functions, assurance and advocacy. Timely accurate surveillance data are essential to assess health needs and to justify the resources needed to provide assurance of effective health protection, health promotion and disease control programs. Such data are also needed by voluntary agencies in their advocacy role to "make the case" with the public and policy makers.
In meeting the challenges of improving health surveillance in Canada, it will be important to have focus and collaboration. Focus is needed to concentrate limited resources on questions of national public health importance and the needs of the major users of health surveillance products. Collaboration is essential for the efficient and effective improvement and sharing of health data. Let us hope that we in the public health surveillance field are up to this challenge.
